Hep B sAg Activators belong to a class of chemical compounds known for their unique ability to interact with and modulate the activity of Hepatitis B surface antigen (HBsAg). HBsAg is a viral protein associated with the Hepatitis B virus (HBV), a major human pathogen responsible for hepatitis B infections. HBsAg is a structural protein that forms the outer envelope of the HBV virion, and it is also released in soluble form into the bloodstream during viral replication. HBsAg plays a critical role in the entry and spread of HBV in host cells, as it mediates viral attachment to host receptors. HBsAg activators are compounds that can influence the expression, stability, or interactions of HBsAg, impacting various aspects of HBV biology, including viral infectivity and propagation.
The mechanism of action of HBsAg activators typically involves their capacity to modulate the expression or secretion of HBsAg or its interactions with host cell receptors. HBsAg is essential for HBV entry into host hepatocytes, as it binds to specific receptors on the cell surface, facilitating viral attachment and internalization. Activators may enhance or inhibit the expression and secretion of HBsAg, affecting the levels of circulating viral particles and the efficiency of viral entry. Additionally, they may influence the interactions of HBsAg with host cell receptors, such as the sodium taurocholate cotransporting polypeptide (NTCP), which is crucial for viral attachment and entry. Understanding the properties and effects of HBsAg activators is significant in the field of virology, as it provides insights into the molecular mechanisms that govern HBV infectivity and the interactions between the virus and host cells. It contributes to our understanding of how specific compounds can influence viral entry and propagation, which are critical aspects of the viral lifecycle.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
This chemical can modulate cellular stress pathways, which might impact HBV replication and sAg assembly. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
As a proteasome inhibitor, Bortezomib can affect cellular pathways that indirectly influence HBV replication and sAg production. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Primarily known as a kinase inhibitor, Sorafenib can alter cellular signaling pathways, potentially impacting HBV lifecycle and sAg expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that can modulate cellular pathways affecting HBV replication and sAg production. | ||||||
Tolvaptan | 150683-30-0 | sc-364638 sc-364638A | 10 mg 50 mg | $125.00 $624.00 | ||
While primarily used for other indications, Tolvaptan might influence cellular pathways that indirectly affect sAg levels. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Known for its immunomodulatory effects, Thalidomide could impact HBV life cycle and sAg assembly indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin may influence cellular pathways related to viral replication and indirectly affect sAg production. | ||||||